Comparison of Tc-99m sestamibi perfusion imaging and echocardiography using an arbutamine infusion for the detection of coronary artery disease

Robert C. Hendel, William Kostuk, Rob S.B. Beanlands, Farooq Chaudry, Kathryn J. Ascah, Helen Young, Terrence D. Ruddy

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Arbutamine, a synthetic catecholamine, coupled with a closed-loop, computerized delivery system was evaluated in conjunction with technetium- 99m sestamibi scintigraphy and echocardiography for the detection of coronary artery disease. Concordance between the imaging methods was 68%, with a similar sensitivity for coronary disease using echocardiography (78%) and technetium-99m sestamibi (76%), although more arbutamine-induced ischemia was noted with perfusion imaging.

Original languageEnglish (US)
Pages (from-to)1518-1521
Number of pages4
JournalAmerican Journal of Cardiology
Volume79
Issue number11
DOIs
StatePublished - Jun 1 1997

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Comparison of Tc-99m sestamibi perfusion imaging and echocardiography using an arbutamine infusion for the detection of coronary artery disease'. Together they form a unique fingerprint.

  • Cite this